Securities code: 603567 securities abbreviation: Heilongjiang Zbd Pharmaceutical Co.Ltd(603567) Announcement No.: pro 2022-002 Heilongjiang Zbd Pharmaceutical Co.Ltd(603567)
Announcement of resolutions of the 13th meeting of the 4th board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Heilongjiang Zbd Pharmaceutical Co.Ltd(603567) the 13th meeting of the Fourth Board of supervisors was held in the company’s conference room on December 31, 2021. Three supervisors should be present at the meeting, and there were actually three. The convening and convening procedures of the meeting shall comply with the relevant provisions of the company law of the people’s Republic of China and the Heilongjiang Zbd Pharmaceutical Co.Ltd(603567) articles of association. The meeting was presided over by Mr. LAN Peibao, chairman of the board of supervisors of the company. After careful discussion, the attending supervisors deliberated and adopted the following matters by voting:
1、 The proposal on using raised funds to replace self raised funds invested in raised investment projects in advance was deliberated and adopted
The company’s replacement of the raised funds does not exceed six months from the arrival of the raised funds. The use of the raised funds to replace the self raised funds invested in the raised projects in advance, so as to improve the use efficiency of the funds, which is in the interests of all shareholders. This capital replacement does not conflict with the implementation plan of the project invested with raised funds, and does not affect the normal progress of the project invested with raised funds. The company’s use of the raised funds to replace the self raised funds invested in the raised investment projects in advance has fulfilled the necessary decision-making procedures, and complies with laws and regulations such as the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of the raised funds of listed companies, the management methods for the raised funds of listed companies on Shanghai Stock Exchange (revised in 2013) The normative documents, the articles of association and the management system of raised funds do not change the investment direction of raised funds and damage the interests of shareholders in a disguised manner.
In conclusion, the board of supervisors agrees that the company will use the raised funds to replace the self raised funds invested in the raised investment projects in advance. Voting results: 3 in favor, 0 against and 0 abstention.
2、 The proposal on using some idle raised funds for cash management was deliberated and adopted
The company uses some idle raised funds for cash management under the condition of ensuring that it will not affect the normal implementation of investment projects with raised funds, change the purpose of raised funds in the same phase, affect the normal operation of the company and ensure the safety of funds, which can improve the use efficiency of raised funds, obtain more investment returns for shareholders and meet the interests of the company. The decision-making procedures for the above matters comply with the provisions of laws, regulations and normative documents such as the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the management methods of raised funds of listed companies on Shanghai Stock Exchange (revised in 2013), the articles of association of the company, the management system of raised funds, etc, It will not have an adverse impact on the company’s business activities and will not damage the interests of the company and all shareholders, especially minority shareholders.
In conclusion, the board of supervisors agreed that the company would use some idle raised funds for cash management.
Voting results: 3 in favor, 0 against and 0 abstention.
It is hereby announced.
Heilongjiang Zbd Pharmaceutical Co.Ltd(603567) board of supervisors January 4, 2022
